Answers are grounded in this paper and cite their sources.
Aims Patient-reported outcome measures (PROMs) are important for capturing patient-centric aspects of disease and treatment. This study evaluated PROMs for advanced or metastatic colorectal cancer (mCRC).Patients & Methods An initial conceptual model (CM) was developed from the published literature, patient blogs, and clinician interviews. Eighteen patients were interviewed; their experience of advanced/mCRC was explored to refine the CM, and PROMs—selected for concept coverage, content validity, and psychometric strength—were evaluated.Results Patients reported 96 symptoms, of which 10 were prioritized as salient (reported by >50% of patients with a bother rating ≥5/10); fatigue was the most salient (n = 18/18; 100%), followed by neuropathy, nausea, and diarrhea (for all: n = 16/18; 88.9%). Of 50 impacts reported, seven were salient; depression and impact on work/employment were most salient (both n = 14/18; 77.8%). The final CM reflects a comprehensive analysis of signs, symptoms, and impacts relevant to patients with advanced/mCRC. Patients found the five selected PROMs—EORTC QLQ-CR29, EORTC QLQ-C30, selected EORTC Library items, FACT-G item GP5, and pain NRS—to be clear, relevant, and representative of their experience.Conclusion This study provides an in-depth view of patients’ experience in advanced/mCRC and could help inform clinical trial protocols, guidelines, and practice.
No takes yet. Share an insight, caveat, or question.
Turnbull et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: